Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients

Summary

This study will investigate the effect of dosing with flutucasone furoate in asthmatic subjects aged 5-11 years of age. A randomized, two-way crossover, with placebo control, over a 14 day treatment period, it will investigate safety, tolerability, pharmacokinetics and serum cortisol levels.

Timeline

Start

2010-05

Primary completion

2011-01

Completion

2011-01

Drugs

Indications